Table 3.
QOL Treatment Outcomes by Group at Follow-up
| Outcomes by group and between-group contrasts | POST | Year 1 | YEAR 2 | Test of Trajectory Differences | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
| Mean (SE) | p | d (95% CI) | Mean (SE) | p | d (95% CI) | Mean (SE) | P | d (95% CI) | Time by Group Interaction | |
|
| ||||||||||
| CES-Depression | F(6, 485.49) = 0.36, p = 0.906 | |||||||||
| Control | 19.19 (1.04) | - | - | 19.03 (1.11) | - | - | 17.57 (1.32) | - | - | |
| 10 Hrs. | 19.26 (1.03) | - | - | 19.18 (1.08) | - | - | 18.99 (1.2) | - | - | |
| 20 Hrs. | 18.37 (0.96) | - | - | 19.59 (1.05) | - | - | 16.81 (1.19) | - | - | |
| Control vs. 10 Hrs. | −0.07 (1.46) | 0.961 | −0.01 (−0.27, 0.25) | −0.15 (1.55) | 0.922 | −0.01 (−0.29, 0.26) | −1.43 (1.78) | 0.424 | −0.13 (−0.45, 0.19) | |
| Control vs. 20 Hrs. | 0.82 (1.42) | 0.564 | 0.07 (−0.18, 0.33) | −0.56 (1.53) | 0.715 | −0.05 (−0.32, 0.22) | 0.76 (1.78) | 0.67 | 0.07 (−0.25, 0.38) | |
| 10 Hrs. vs. 20 Hrs. | 0.89 (1.41) | 0.529 | 0.08 (−0.17, 0.33) | −0.41 (1.51) | 0.788 | −0.04 (−0.30, 0.23) | 2.18 (1.69) | 0.197 | 0.20 (−0.10, 0.50) | |
| Locus of Control | F(6, 486.8) = 1.35, p = 0.234 | |||||||||
| Control | 28.47 (0.52) | - | - | 28.67 (0.56) | - | - | 29.9 0(0.67) | - | - | |
| 10 Hrs. | 28.31 (0.52) | - | - | 27.91 (0.55) | - | - | 27.57 (0.61) | - | - | |
| 20 Hrs. | 28.74 (0.49) | - | - | 27.76 (0.53) | - | - | 28.75 (0.60) | - | - | |
| Control vs. 10 Hrs. | 0.17 (0.74) | 0.819 | 0.03 (−0.21, 0.26) | 0.76 (0.78) | 0.333 | 0.12 (−0.13, 0.37) | 2.33 (0.90) | 0.01 | 0.38 (0.09, 0.67) | |
| Control vs. 20 Hrs. | −0.26 (0.72) | 0.712 | −0.04 (−0.27, 0.19) | 0.91 (0.78) | 0.24 | 0.15 (−0.10, 0.40) | 1.16 (0.90) | 0.2 | 0.19 (−0.10, 0.48) | |
| 10 Hrs. vs. 20 Hrs. | −0.43 (0.71) | 0.545 | −0.07 (−0.3, 0.16) | 0.15 (0.76) | 0.842 | 0.02 (−0.22, 0.27) | −1.18 (0.86) | 0.169 | −0.19 (−0.47, 0.08) | |
| PSQI Sleep Quality | F(6, 490.32) = 2.44, p = 0.024 | |||||||||
| Control | 9.1 (0.45) | - | - | 9.54 (0.49) | - | - | 8.14 (0.58) | - | - | |
| 10 Hrs. | 9.7 (0.45) | - | - | 10.78 (0.47) | - | - | 9.63 (0.53) | - | - | |
| 20 Hrs. | 9.04 (0.42) | - | - | 8.83 (0.46) | - | - | 9.65 (0.52) | - | - | |
| Control vs. 10 Hrs. | −0.6 (0.64) | 0.347 | −0.14 (−0.43, 0.15) | −1.24 (0.68) | 0.068 | −0.29 (−0.59, 0.02) | −1.49 (0.78) | 0.057 | −0.34 (−0.70, 0.01) | |
| Control vs. 20 Hrs. | 0.07 (0.62) | 0.913 | 0.02 (−0.27, 0.3) | 0.71 (0.67) | 0.29 | 0.16 (−0.14, 0.47) | −1.51 (0.78) | 0.054 | −0.35 (−0.70, 0.01) | |
| 10 Hrs. vs. 20 Hrs. | 0.67 (0.62) | 0.28 | 0.15 (−0.13, 0.43) | 1.96 (0.66) | 0.003 | 0.45 (0.15, 0.75) | −0.02 (0.74) | 0.982 | 0 (−0.34, 0.33) | |
| MOS-HIV General Health Perceptions | F(6, 482.04) = 0.14, p = 0.992 | |||||||||
| Control | 52.5 (2.38) | - | - | 52.49 (2.56) | - | - | 53.96 (3.03) | - | - | |
| 10 Hrs. | 54.52 (2.38) | - | - | 52.57 (2.49) | - | - | 52.86 (2.77) | - | - | |
| 20 Hrs. | 53.55 (2.23) | - | - | 52.6 (2.43) | - | - | 55.18 (2.73) | - | - | |
| Control vs. 10 Hrs. | −2.02 (3.36) | 0.548 | −0.08 (−0.32, 0.17) | −0.08 (3.57) | 0.982 | 0 (−0.26, 0.26) | 1.11 (4.11) | 0.788 | 0.04 (−0.26, 0.34) | |
| Control vs. 20 Hrs. | −1.05 (3.27) | 0.748 | −0.04 (−0.28, 0.2) | −0.12 (3.54) | 0.974 | 0 (−0.26, 0.25) | −1.22 (4.09) | 0.765 | −0.05 (−0.34, 0.25) | |
| 10 Hrs. vs. 20 Hrs. | 0.97 (3.27) | 0.766 | 0.04 (−0.2, 0.27) | −0.04 (3.49) | 0.992 | 0 (−0.26, 0.25) | −2.33 (3.89) | 0.551 | −0.09 (−0.37, 0.20) | |
| MOS-HIV HRQoL - Physical Summary | F(6, 482.14) = 0.79, p = 0.581 | |||||||||
| Control | 44.98 (0.95) | - | - | 44.08 (1.01) | - | - | 45.7 (1.20) | - | - | |
| 10 Hrs. | 44.77 (0.94) | - | - | 46.74 (0.98) | - | - | 46.5 (1.09) | - | - | |
| 20 Hrs. | 46.07 (0.88) | - | - | 44.75 (0.96) | - | - | 46.77 (1.08) | - | - | |
| Control vs. 10 Hrs. | 0.22 (1.33) | 0.872 | 0.02 (−0.21, 0.25) | -2.66 (1.41) | 0.06 | −0.23 (−0.47, 0.01) | −0.8 (1.62) | 0.62 | −0.07 (−0.35, 0.21) | |
| Control vs. 20 Hrs. | −1.08 (1.30) | 0.403 | −0.09 (−0.31, 0.13) | −0.67 (1.40) | 0.63 | −0.06 (−0.3, 0.18) | −1.08 (1.62) | 0.505 | −0.09 (−0.37, 0.18) | |
| 10 Hrs. vs. 20 Hrs. | −1.30 (1.29) | 0.315 | −0.11 (−0.33, 0.11) | 1.99 (1.38) | 0.149 | 0.17 (−0.06, 0.41) | −0.27 (1.54) | 0.859 | −0.02 (−0.29, 0.24) | |
| MOS-HIV HRQoL - Mental Summary | F(6, 479.08) = 0.61, p = 0.719 | |||||||||
| Control | 45.81 (1.05) | - | - | 46.49 (1.12) | - | - | 48.15 (1.33) | - | - | |
| 10 Hrs. | 48.12 (1.05) | - | - | 48.39 (1.10) | - | - | 48.6 (1.21) | - | - | |
| 20 Hrs. | 47.47 (0.98) | - | - | 47.11 (1.06) | - | - | 50.12 (1.20) | - | - | |
| Control vs. 10 Hrs. | −2.31 (1.49) | 0.121 | −0.2 (−0.45, 0.05) | −1.90 (1.57) | 0.226 | −0.16 (−0.43, 0.1) | −0.45 (1.80) | 0.803 | −0.04 (−0.34, 0.26) | |
| Control vs. 20 Hrs. | −1.66 (1.44) | 0.249 | −0.14 (−0.39, 0.10) | −0.62 (1.55) | 0.689 | −0.05 (−0.31, 0.21) | −1.97 (1.79) | 0.271 | −0.17 (−0.47, 0.13) | |
| 10 Hrs. vs. 20 Hrs. | 0.65 (1.44) | 0.653 | 0.06 (−0.19, 0.30) | 1.28 (1.53) | 0.404 | 0.11 (−0.15, 0.37) | −1.52 (1.71) | 0.374 | −0.13 (−0.42, 0.16) | |
Notes. Estimates from longitudinal models adjusted for baseline outcome, baseline MOS-HIV General Health Perception, baseline MOS-HIV Physical Summary, baseline number of prescriptions, and Nadir CD4. Cohen’s d: ~0.2 small, ~0.5 medium, ~0.8 large. CES-Depression = Center for Epidemiological Studies Depression Scale; HRQoL = health-related quality of life; MOS-HIV = Medical Outcomes Study – HIV; PSQI = Pittsburgh Sleep Quality Index; SE = Standard Error. No test of trajectory differences was statistically significant at a 10% False Discovery Rate level.